メインコンテンツにスキップ

Simcyp PBPK Simulatorをお客様の医薬品開発プログラムに統合する10のメリット

Per US FDA’s recent paper on the topic, Physiologically based Pharmacokinetic (PBPK) modeling & simulation impact on drug approval has grown significantly over the past years, with about 45% percentage of new drug approvals including PBPK analyses in 2019 [1]. Another paper showed a rise of more than 280% in pharmaceutical applications of PBPK M&S … Continued

1 of 1
Powered by Translations.com GlobalLink OneLink Software